Relationship between ERCC5+25A＞G polymorphism and clinical outcome of patients with advanced colorectal cancer treated with platinum-based chemotherapy

CHEN Jian-fang; LIANG Hou-jie; ZOU Lan; JIANG Jin-yan; CHEN Ke-li; WANG Dong; LIAO Ling

doi:10.3969/j.issn.1009-0460.2011.01.002

Home>Articles>Relationship between ERCC5+25A＞G polymorphism and clinical outcome of patients with advanced colorectal cancer treated with platinum-based chemotherapy

DOI: 10.3969/j.issn.1009-0460.2011.01.002

Relationship between ERCC5+25A＞G polymorphism and clinical outcome of patients with advanced colorectal cancer treated with platinum-based chemotherapy

CHEN Jian-fang

LIANG Hou-jie

ZOU Lan

JIANG Jin-yan

CHEN Ke-li

WANG Dong

LIAO Ling

Machine-generated Keywords：

Publication Date：2011-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 9-13 )

CHINESE CLINICAL ONCOLOGY

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2011,16(1)